Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reflex Responses to Intermittent Hypoxia in Humans
NCT05146089Phase 1Completed
- Sponsor
- University of Missouri
- Start
- Dec 2016
- Primary completion
- Sep 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of bosentan in sleep apnea, sponsored by University of Missouri. Primary endpoint: Muscle Sympathetic Nerve Activity. Started Dec 2016; status: completed.
02
Drugs
bosentan
03
Conditions
sleep apnea
Beyond the preview
Go deeper on NCT05146089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05146089.